Lataa...
Maintenance of Androgen Receptor Inactivation by S-nitrosylation
Anti-androgens target ligand binding domain of AR and are used as frontline therapeutics to treat patients diagnosed with locally advanced and metastatic prostate cancer. Although initially beneficial as judged with actual tumor mass shrinkage, this therapy invariably fails and the cancer reappears...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3861894/ https://ncbi.nlm.nih.gov/pubmed/24121486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-1042 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|